Mindstate Design Labs is a clinical-stage AI neuroengineering and drug development company. Its Osmanthus discovery platform fuses human reports of psychoactive effects with biochemical data using multi-agent LLMs, custom embeddings, Bayesian neural networks, and other ML methods to map how neurotransmitter receptor combinations produce distinct emotional and cognitive states. The company’s pipeline includes MSD programs aimed at precision-designing therapeutic states such as empathy or awe, with human studies underway.